| Nasdaq: QDEL
Quidel Corp. develops, manufactures and markets rapid diagnostic testing solutions. Its solutions are provided under various brands such as QuickVue, QuickVue+, Quidel, MicroVue, FreshCells, D FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, and Thyretain. The company primarily includes applications in infectious diseases, women's health and gastrointestinal diseases. It sells products to physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics and wellness screening centers. Quidel was founded in 1979 and is headquartered in San Diego, CA.